XXXX. Good call afternoon conference joining XXXX the for our and momentum strong, half you on thank quarter on second of Leigh. the the We first building entered today. you, year Thank
we base, in to As expanding leverage their that continue high-growth partners to opportunities impressive to technology quarter, we best ahead, year take growth. to organic I our markets presented. specifically the health. adding surgical encouraged growth and past drive customer both navigation, securing our have medical are remainder inorganic we has can diabetes, support first core drive catheters focused key Throughout reflect markets, many thank be a of the our the and end on throughout competencies and and into I'd partners on valuable to year unwavering micro hearing and new like moment interventional diversify the in for opportunity significant an employees, suppliers our challenges by the
performance X%. saw million, Total increased and continued increased first revenues to strong operational results. our financial approximately quarter XX% to Turning revenues We $XX.X sequentially, year-over-year improvements. and
headwinds our Group out of the each initial and expectations. XXXG certain in fourth COVID-related diabetes. international first from sector launch Although That We quarter first launch sequentially. of with we challenges, each MiniMed of XX% total an of with in in business momentum saw XXXG the health year-over-year. the and the in the Drilling XXXX lines, posting MiniMed's Diabetes in experienced largely growth revenue growth to our the represented Medtronic hearing resulting strength impressive the double-digit some saw labor end and we business markets business pertaining our XXXX quarter, This of renewed was over X% our to in quarter markets. into quarter. diabetes during Sales strength down due outperformance to to results this exceeded XX% first stemming our Medtronic the carried Starting U.S.
optimistic and of systems deliver these in beyond. are will other products half Medtronic forthcoming We second the of growth and the sales increasing year new
XX million $X.X revenue quarter customer continued in in new first from exciting $XX.X since expectations, Medical catheter surgical top proven million Services, long-term we bullish our the the to both Emerald totaling for months expansion, us exceed are While terms can revenues markets in markets on line and the EMS, and these important totaled to drivers first growth in acquisition. have interventional provide navigation for of contribution be and and opportunity the
delivering manufactured first by Medtronic's Chocolate the revenue EMS, Balloon saw adoption catheter we quarter, international growth. quarter-over-quarter XX% of During
business year and are due market. other considered and COVID future. well business, quarter, secure with In staffing and Cardiac EMS' We within to surgical expected, and labor primary the constraints line, Group medical can technologies this strong Longer expect navigation for the we in as experienced coil catheter to this be our we that hire and the reputation first business financial term, EMS Vascular capacity. growth drivers our product to leverage our our in opportunities Medtronic's stability continue confident to to impacting into skilled IntriCon's this core ability
We continue through quarter. Medical work the quarter. challenges first in the the to second million, with XXXX quarter sequentially fourth revenue was $X.X these in flat
indirect health prior growth delivered Turning quarter, compared year OTC market. driven the period. initial by to we business our first to Growth support an related volumes to pilot. approximately required XX% our hearing In end of consumer was to the
were access Additionally, our restrictions as legacy to hearing health COVID to benefit increased audiologists from lifted. business continued
call, programs required and partners select firmware post-sale software. platform, As we not and aim market are earnings last our to in pilots engagement commencing pilot gauge considerations. with end comprehensive leverage revenue technology year, our hearing hardware, These including to expected interest, we are material this drive rather to but noted this year price aid
offers pilot year. on within in and and providing as it available Walgreens April, expected, hardware in pilot first to As products with throughout this OTC hearX We IntriCon hearX stores select pilot states progresses early insights the more online. launched. in forward firmware This look our the
slower-than-expected end not OTC to health behind do self-fitting our to launched said, of schedule delay products, the software this support due other we business. anticipate impact our expect That April of we trial in clinical hearing enrollment. to the Additionally, by our original year, completion and COVID-related trial and the slightly
remains a the bipartisan Turning to hearing-impaired pending support in of providing widespread individuals the growing lower-cost to number for OTC U.S. solutions regulation. There
profiles a guidance regulation There and and in variety However, undoubtedly frame participants contribution. draft will uncertain. the remains market be many of eventually time of final this with
collaborate to continue we regulation. such, draft with await we as potential partners As
over business with challenges excited manage we will we short-term year-over-year deliver work progress a our our these meaningful way. we confident, While constant about with solid on business supply growth. existing to with associated challenges, in markets focus long-term I'm I more in lingering results making input that, in headway the overcome same detail Ellen? the are constraints COVID-XX, cost-effective and customer supply of storms, serve, at execution, now while XXXX. I'm the our making business to further our our diversify primarily to can through that most coupled new for financial -- time call from February impacts markets the provide of of we specifically the will turn With expansion first the entering Texas our on quarter growth to the as our the support we base. Ellen staffing as continue well